MedPath

BR900A

Generic Name
BR900A

To Evaluate the Pharmacokinetics and Safety of Oral Administration of BR9001 Compared With BR900A in Healthy Subjects

Phase 1
Completed
Conditions
Rheumatoid Arthritis
Interventions
First Posted Date
2018-10-24
Last Posted Date
2019-07-08
Lead Sponsor
Boryung Pharmaceutical Co., Ltd
Target Recruit Count
36
Registration Number
NCT03718611
Locations
🇰🇷

Kyungpook National University Hospital, Daegu, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath